Cargando…

Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss

The differentiation shift from osteogenesis to adipogenesis of bone marrow mesenchymal stem cells (BMSCs) characterizes many pathological bone loss conditions. Stromal cell-derived factor-1 (SDF1) is highly enriched in the bone marrow for C-X-C motif chemokine receptor 4 (CXCR4)-positive hematopoiet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yan, Li, Xiaoqun, Zhang, Qin, Gu, Zhengrong, Luo, Ying, Guo, Jiawei, Wang, Xiuhui, Jing, Yingying, Chen, Xiao, Su, Jiacan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917458/ https://www.ncbi.nlm.nih.gov/pubmed/33718671 http://dx.doi.org/10.1016/j.bioactmat.2021.02.014

Ejemplares similares

Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss
por: Li, Xiaoqun, et al.
Publicado: (2020)

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
por: Guo, Jiawei, et al.
Publicado: (2023)

Exosome-Laden Hydrogels: A Novel Cell-free Strategy for In-situ Bone Tissue Regeneration
por: Sun, Jinru, et al.
Publicado: (2022)

Lactulose Suppresses Osteoclastogenesis and Ameliorates Estrogen Deficiency-Induced Bone Loss in Mice
por: Chen, Xiao, et al.
Publicado: (2019)

Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis
por: Wang, Jianguo, et al.
Publicado: (2020)

A novel biologically hierarchical hydrogel with osteoblast precursor‐targeting extracellular vesicles ameliorates bone loss in vivo via the sequential action of antagomiR‐200b‐3p and antagomiR‐130b‐3p
por: Dai, Hanhao, et al.
Publicado: (2023)

Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease
por: Chen, Yulin, et al.
Publicado: (2022)

Betaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone
por: Yajun, Wang, et al.
Publicado: (2021)

Mechanisms of bone anabolism regulated by statins
por: Ruan, Feng, et al.
Publicado: (2012)

Anabolic Therapies in Osteoporosis and Bone Regeneration
por: Russow, Gabriele, et al.
Publicado: (2018)

Antagomirbase- a putative antagomir database
por: Ganguli, Sayak, et al.
Publicado: (2011)

Mesenchymal Stem Cells Attenuate Renal Fibrosis via Exosomes-Mediated Delivery of microRNA Let-7i-5p Antagomir
por: Jin, Juan, et al.
Publicado: (2021)

Reactive Oxygen Species (ROS)-Responsive Biomaterials for the Treatment of Bone-Related Diseases
por: Ren, Xiaoxiang, et al.
Publicado: (2022)

Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC
por: Kasinski, Andrea L, et al.
Publicado: (2012)

Anabolic Strategies to Augment Bone Fracture Healing
por: Roberts, Scott J., et al.
Publicado: (2018)

Nerves in Bone: Evolving Concepts in Pain and Anabolism
por: Brazill, Jennifer M, et al.
Publicado: (2019)

Bone Biology and Anabolic Therapies for Bone: Current Status and Future Prospects
por: Martin, T. John
Publicado: (2014)

Role of bone-anabolic agents in the treatment of breast cancer bone metastases
por: Suvannasankha, Attaya, et al.
Publicado: (2014)

Specificity, duplex degradation and subcellular localization of antagomirs
por: Krützfeldt, Jan, et al.
Publicado: (2007)

Research Progress of Exosomes in Bone Diseases: Mechanism, Diagnosis and Therapy
por: Meng, Fanying, et al.
Publicado: (2022)

PTHG2 Reduces Bone Loss in Ovariectomized Mice by Directing Bone Marrow Mesenchymal Stem Cell Fate
por: Chen, Jiao, et al.
Publicado: (2021)

(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018)

Cell unit-inspired natural nano-based biomaterials as versatile building blocks for bone/cartilage regeneration
por: Wang, Fuxiao, et al.
Publicado: (2023)

Loss of Bcl-3 delays bone fracture healing through activating NF-κB signaling in mesenchymal stem cells
por: Wang, Fuxiao, et al.
Publicado: (2022)

Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization
por: Zhou, Xin, et al.
Publicado: (2022)

Frequent, quantitative bone planar scintigraphy for determination of bone anabolism in growing mice
por: Zaloszyc, Ariane, et al.
Publicado: (2021)

Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
por: Tao, Yaoye, et al.
Publicado: (2020)

Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy
por: Reschke, Cristina R., et al.
Publicado: (2021)

Connexin hemichannels with prostaglandin release in anabolic function of bone to mechanical loading
por: Zhao, Dezhi, et al.
Publicado: (2022)

Reversal of the diabetic bone signature with anabolic therapies in mice
por: Marino, Silvia, et al.
Publicado: (2023)

Bovine bone particulates containing bone anabolic factors as a potential xenogenic bone graft substitute
por: Musson, David S., et al.
Publicado: (2019)

A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation
por: Jiang, Min, et al.
Publicado: (2020)

Subchondral bone microenvironment in osteoarthritis and pain
por: Hu, Yan, et al.
Publicado: (2021)

Vitamin A decreases the anabolic bone response to mechanical loading by suppressing bone formation
por: Lionikaite, Vikte, et al.
Publicado: (2019)

Involvement of serum‐derived exosomes of elderly patients with bone loss in failure of bone remodeling via alteration of exosomal bone‐related proteins
por: Xie, Yong, et al.
Publicado: (2018)

Anabolic Steroids and Bone Marrow Toxicity During Therapy with Methotrexate
por: Rawbone, R. G., et al.
Publicado: (1972)

Molecular signaling mechanisms behind polyphenol-induced bone anabolism
por: Torre, Elisa
Publicado: (2017)

Stimulation of Piezo1 by mechanical signals promotes bone anabolism
por: Li, Xuehua, et al.
Publicado: (2019)

Romosozumab: a novel bone anabolic treatment option for osteoporosis?
por: Kerschan-Schindl, Katharina
Publicado: (2019)

P2Y Receptors in Bone - Anabolic, Catabolic, or Both?
por: Zhou, Yuhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4u2ltmsu29kse07l0ebj22gvit